Cassava Sciences earnings beat by $0.06, revenue was in line with estimates

  • Investing.com
Cassava Sciences earnings beat by $0.06, revenue was in line with estimates

Investing.com - Cassava Sciences (NASDAQ: SAVA) reported first quarter EPS of $-0.58, $0.06 better than the analyst estimate of $-0.64. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.

Cassava Sciences's stock price closed at $23.22. It is down -19.37% in the last 3 months and up 12.74% in the last 12 months.

Cassava Sciences saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Cassava Sciences's stock price’s past reactions to earnings here.

According to InvestingPro, Cassava Sciences's Financial Health score is "weak performance".

Check out Cassava Sciences's recent earnings performance , and Cassava Sciences's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles